Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort

<p>Abstract</p> <p>Background</p> <p>Among children, early mortality following highly active antiretroviral therapy (HAART) remains high. It is important to define correlates of mortality in order to improve outcome.</p> <p>Methods</p> <p>HIV-1-i...

Full description

Bibliographic Details
Main Authors: Mbori-Ngacha Dorothy A, Richardson Barbra A, Farquhar Carey, Obimbo Elizabeth M, Wamalwa Dalton C, Inwani Irene, Benki-Nugent Sara, John-Stewart Grace
Format: Article
Language:English
Published: BMC 2010-05-01
Series:BMC Pediatrics
Online Access:http://www.biomedcentral.com/1471-2431/10/33
id doaj-3da6c26864a74ff7b2e045dbbe0d2dfb
record_format Article
spelling doaj-3da6c26864a74ff7b2e045dbbe0d2dfb2020-11-25T00:58:02ZengBMCBMC Pediatrics1471-24312010-05-011013310.1186/1471-2431-10-33Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohortMbori-Ngacha Dorothy ARichardson Barbra AFarquhar CareyObimbo Elizabeth MWamalwa Dalton CInwani IreneBenki-Nugent SaraJohn-Stewart Grace<p>Abstract</p> <p>Background</p> <p>Among children, early mortality following highly active antiretroviral therapy (HAART) remains high. It is important to define correlates of mortality in order to improve outcome.</p> <p>Methods</p> <p>HIV-1-infected children aged 18 months-12 years were followed up at Kenyatta National Hospital, Nairobi after initiating NNRTI-based HAART. Cofactors for mortality were determined using multivariate Cox regression models.</p> <p>Results</p> <p>Between August 2004 and November 2008, 149 children were initiated on HAART of whom 135 were followed for a total of 238 child-years (median 21 months) after HAART initiation. Baseline median CD4% was 6.8% and median HIV-1-RNA was 5.98-log<sub>10 </sub>copies/ml. Twenty children (13.4%) died at a median of 35 days post-HAART initiation. Mortality during the entire follow-up period was 8.4 deaths per 100 child-years (46 deaths/100 child-years in first 4 months and 1.0 deaths/100 child-years after 4 months post-HAART initiation). On univariate Cox regression, baseline hemoglobin (Hb) <9 g/dl, weight-for-height z-score (WHZ) < -2, and WHO clinical stage 4 were associated with increased risk of death (Hb <9 g/dl HR 3.00 [95% C.I. 1.21-7.39], p = 0.02, WHZ < -2 HR 3.41 [95% C.I. 1.28-9.08], p = 0.01, and WHO clinical stage 4, HR 3.08 [1.17-8.12], p = 0.02). On multivariate analysis Hb < 9 g/dl remained predictive of mortality after controlling for age, baseline CD4%, WHO clinical stage and weight-for-height z-score (HR 2.95 (95% C.I. 1.04-8.35) p = 0.04).</p> <p>Conclusion</p> <p>High early mortality was observed in this cohort of Kenyan children receiving HAART, and low baseline hemoglobin was an independent risk factor for death.</p> http://www.biomedcentral.com/1471-2431/10/33
collection DOAJ
language English
format Article
sources DOAJ
author Mbori-Ngacha Dorothy A
Richardson Barbra A
Farquhar Carey
Obimbo Elizabeth M
Wamalwa Dalton C
Inwani Irene
Benki-Nugent Sara
John-Stewart Grace
spellingShingle Mbori-Ngacha Dorothy A
Richardson Barbra A
Farquhar Carey
Obimbo Elizabeth M
Wamalwa Dalton C
Inwani Irene
Benki-Nugent Sara
John-Stewart Grace
Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
BMC Pediatrics
author_facet Mbori-Ngacha Dorothy A
Richardson Barbra A
Farquhar Carey
Obimbo Elizabeth M
Wamalwa Dalton C
Inwani Irene
Benki-Nugent Sara
John-Stewart Grace
author_sort Mbori-Ngacha Dorothy A
title Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
title_short Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
title_full Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
title_fullStr Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
title_full_unstemmed Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
title_sort predictors of mortality in hiv-1 infected children on antiretroviral therapy in kenya: a prospective cohort
publisher BMC
series BMC Pediatrics
issn 1471-2431
publishDate 2010-05-01
description <p>Abstract</p> <p>Background</p> <p>Among children, early mortality following highly active antiretroviral therapy (HAART) remains high. It is important to define correlates of mortality in order to improve outcome.</p> <p>Methods</p> <p>HIV-1-infected children aged 18 months-12 years were followed up at Kenyatta National Hospital, Nairobi after initiating NNRTI-based HAART. Cofactors for mortality were determined using multivariate Cox regression models.</p> <p>Results</p> <p>Between August 2004 and November 2008, 149 children were initiated on HAART of whom 135 were followed for a total of 238 child-years (median 21 months) after HAART initiation. Baseline median CD4% was 6.8% and median HIV-1-RNA was 5.98-log<sub>10 </sub>copies/ml. Twenty children (13.4%) died at a median of 35 days post-HAART initiation. Mortality during the entire follow-up period was 8.4 deaths per 100 child-years (46 deaths/100 child-years in first 4 months and 1.0 deaths/100 child-years after 4 months post-HAART initiation). On univariate Cox regression, baseline hemoglobin (Hb) <9 g/dl, weight-for-height z-score (WHZ) < -2, and WHO clinical stage 4 were associated with increased risk of death (Hb <9 g/dl HR 3.00 [95% C.I. 1.21-7.39], p = 0.02, WHZ < -2 HR 3.41 [95% C.I. 1.28-9.08], p = 0.01, and WHO clinical stage 4, HR 3.08 [1.17-8.12], p = 0.02). On multivariate analysis Hb < 9 g/dl remained predictive of mortality after controlling for age, baseline CD4%, WHO clinical stage and weight-for-height z-score (HR 2.95 (95% C.I. 1.04-8.35) p = 0.04).</p> <p>Conclusion</p> <p>High early mortality was observed in this cohort of Kenyan children receiving HAART, and low baseline hemoglobin was an independent risk factor for death.</p>
url http://www.biomedcentral.com/1471-2431/10/33
work_keys_str_mv AT mboringachadorothya predictorsofmortalityinhiv1infectedchildrenonantiretroviraltherapyinkenyaaprospectivecohort
AT richardsonbarbraa predictorsofmortalityinhiv1infectedchildrenonantiretroviraltherapyinkenyaaprospectivecohort
AT farquharcarey predictorsofmortalityinhiv1infectedchildrenonantiretroviraltherapyinkenyaaprospectivecohort
AT obimboelizabethm predictorsofmortalityinhiv1infectedchildrenonantiretroviraltherapyinkenyaaprospectivecohort
AT wamalwadaltonc predictorsofmortalityinhiv1infectedchildrenonantiretroviraltherapyinkenyaaprospectivecohort
AT inwaniirene predictorsofmortalityinhiv1infectedchildrenonantiretroviraltherapyinkenyaaprospectivecohort
AT benkinugentsara predictorsofmortalityinhiv1infectedchildrenonantiretroviraltherapyinkenyaaprospectivecohort
AT johnstewartgrace predictorsofmortalityinhiv1infectedchildrenonantiretroviraltherapyinkenyaaprospectivecohort
_version_ 1725221655283761152